Whalegun
Home

Biomarin Pharmaceutical BMRN spent $270K on lobbying in Q3 2025 · Budget, Health Issues and 3 more issues

Trade details

Type
Lobbying report
Amount
$270,000
Quarter
Q3 2025
Stock
Biomarin Pharmaceutical BMRN
Client
Biomarin Pharmaceutical
Reported
25/10/20

Up 0.0% from last quarter

What else happened in Biomarin Pharmaceutical around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Biomarin Pharmaceutical's other lobbying reports